HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.

AuthorsK M Gibson, C Jakobs, H Ogier, L Hagenfeldt, K E Eeg-Olofsson, O Eeg-Olofsson, F Aksu, H P Weber, E Rossier, B Vollmer
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 18 Issue 2 Pg. 143-6 ( 1995) ISSN: 0141-8955 [Print] United States
PMID7564230 (Publication Type: Journal Article)
Chemical References
  • GABA Antagonists
  • gamma-Aminobutyric Acid
  • Sodium Oxybate
  • Aldehyde Oxidoreductases
  • ALDH5A1 protein, human
  • Succinate-Semialdehyde Dehydrogenase
  • 4-Aminobutyrate Transaminase
  • Vigabatrin
Topics
  • 4-Aminobutyrate Transaminase (antagonists & inhibitors)
  • Aldehyde Oxidoreductases (deficiency)
  • Brain Diseases, Metabolic (complications, drug therapy)
  • GABA Antagonists (adverse effects, therapeutic use)
  • Humans
  • Metabolism, Inborn Errors (complications, drug therapy)
  • Seizures (chemically induced)
  • Sodium Oxybate (cerebrospinal fluid)
  • Succinate-Semialdehyde Dehydrogenase
  • Treatment Outcome
  • Vigabatrin
  • gamma-Aminobutyric Acid (adverse effects, analogs & derivatives, cerebrospinal fluid, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: